Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

434
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
434
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

121
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
121
Drug Concentration Versus Time Correlation01:15

Drug Concentration Versus Time Correlation

1.1K
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Cluster Analysis of Clinician Distress Trajectories when Caring for Seriously Ill Hospitalized Patients.

Journal of palliative medicine·2026
Same author

Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer.

Journal of the National Cancer Institute·2026
Same author

Acceptability and Feasibility of a Problem-Solving Intervention for Maternal Caregivers of Young Adult Survivors of Childhood Brain Tumors.

Psycho-oncology·2026
Same author

Factors Related to Long-Term Caregiving Burden Among Chimeric Antigen Receptor (CAR) T-Cell Recipients and Their Informal Caregivers.

Seminars in oncology nursing·2025
Same author

Over 50 years of research on social disparities in pain and pain treatment: a scoping review of reviews.

Pain·2025
Same author

Long-Term Financial Toxicity After CAR T-Cell Therapy Among Patients in Remission and Their Caregivers.

Transplantation and cellular therapy·2025

Related Experiment Video

Updated: Sep 2, 2025

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram
09:00

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram

Published on: July 7, 2023

3.7K

Modeling Individual Patient Count/Rate Data over Time with Applications to Cancer Pain Flares and Cancer Pain

George J Knafl1, Salimah H Meghani2

  • 1School of Nursing, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Open Journal of Statistics
|August 8, 2022
PubMed
Summary

This study introduces two advanced statistical methods for analyzing patient count data over time, accounting for complex correlations and varying data spread. Extended linear mixed modeling proved more effective and efficient for this type of data.

Keywords:
Adaptive RegressionExtended Linear Mixed ModelingGeneralized Estimating EquationsLikelihood-Like Cross-ValidationPoisson Regression

More Related Videos

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K

Related Experiment Videos

Last Updated: Sep 2, 2025

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram
09:00

Author Spotlight: Quantifying Pain Experience – An Illustrative Approach Using the Pain Body Diagram

Published on: July 7, 2023

3.7K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.8K
Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

12.8K

Area of Science:

  • Biostatistics
  • Statistical Modeling
  • Longitudinal Data Analysis

Background:

  • Analyzing individual patient count/rate data over time presents challenges due to temporal correlations and non-constant dispersions.
  • Existing methods may require extensive computational time for model selection.

Purpose of the Study:

  • To investigate and compare two extended generalized estimating equations (GEE) modeling approaches for individual patient count/rate data.
  • To develop methods that efficiently search for optimal models while accounting for temporal dynamics and dispersion.
  • To evaluate model performance using a likelihood-like cross-validation (LCV) score.

Main Methods:

  • Two extensions of generalized estimating equations (GEE) were formulated using a multivariate normal density-based likelihood-like function.
  • The first approach augments GEE with dispersion parameter estimation equations.
  • The second approach extends linear mixed modeling by deriving estimating equations from the partial derivatives of the likelihood-like function.
  • Three correlation structures (independent, exchangeable, spatial autoregressive) were considered.
  • Adaptive regression modeling and LCV scores were used for model selection.

Main Results:

  • Extended linear mixed modeling demonstrated superior performance in example analyses of cancer patient count/rate data.
  • This approach yielded better LCV scores and/or more parsimonious models compared to the augmented GEE approach.
  • The extended linear mixed modeling approach required substantially less computation time.

Conclusions:

  • Extended linear mixed modeling is a preferable method for analyzing individual patient count/rate data over time.
  • This approach effectively handles temporal correlations and non-constant dispersions while allowing for efficient model selection.
  • The findings support the use of extended linear mixed modeling for complex longitudinal count data in clinical research.